Systematic review and Meta-analysis of efficacy and safety of Ningxinbao Capsules in treatment of arrhythmia.
10.19540/j.cnki.cjcmm.20200702.502
- Author:
Jun-di JIA
1
;
Yu-Feng LI
1
;
Min XIAO
1
;
Xu JIANG
1
;
Sheng-Yao XIU
1
;
Jie WANG
1
Author Information
1. Dongzhimen Hospital,Beijing University of Chinese Medicine Beijing 100700,China.
- Publication Type:Systematic Review
- Keywords:
Meta-analysis;
Ningxinbao Capsules;
arrhythmia;
systematic review
- MeSH:
Bradycardia;
Capsules;
Drugs, Chinese Herbal/adverse effects*;
Humans;
Treatment Outcome
- From:
China Journal of Chinese Materia Medica
2021;46(5):1260-1267
- CountryChina
- Language:Chinese
-
Abstract:
To systematically evaluate the efficacy and safety of Ningxinbao Capsules in treatment of arrhythmia by Meta-analysis. Randomized controlled trial(RCT) or quasi-randomized control trial(Quasi-RCT) on Ningxinbao Capsules treating arrhythmia were obtained by computer-based retrieval in CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Cochrane Library and EMbase as well as manual retrieval, with time limit from database establishment to April 7, 2020. According to the inclusion and exclusion criteria of trials, all RCTs were screened and evaluated. Then the effective data were collected and RevMan 5.3 Meta-analysis software was used for analysis. Thirteen trials were included, involving 1 379 patients in total. Ningxinbao Capsules combined with anti-arrhythmia Western medicine were adopted as the intervention, and the patients in control group were treated with the anti-arrhythmia Western medicine alone. Meta-analysis results showed that as compared to control group, Ningxinbao Capsules combined with anti-arrhythmia Western medicine group was superior in clinical efficacy, dynamic electrocardiogram and average heart rate in patients with bradycardia, with indicated statistically significant differences. Ningxinbao Capsules had fewer adverse reactions and could relieve the toxic and side effects of anti-arrhythmia medicine possibly. The study showed that Ningxinbao Capsules played a role in treatment of arrhythmia and was relatively safe. However, due to the limited quality of the included studies, high-quality clinical trials are needed to verify the conclusions.
